What's new in the treatment of neonatal shock

被引：7

作者：

Caresta, Elena ^{[1
]}

Papoff, Paola ^{[1
]}

Valentini, Sara Benedetti ^{[1
]}

Mancuso, Michele ^{[1
]}

Cicchetti, Roberto ^{[1
]}

Midulla, Fabio ^{[1
]}

Moretti, Corrado ^{[1
]}

机构：

[1] Univ Roma La Sapienza, Dept Pediat, Rome, Italy

来源：

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE | 2011年 / 24卷

关键词：

neonatal shock; sepsis; treatment; SEPTIC SHOCK; LEVOSIMENDAN;

D O I：

10.3109/14767058.2011.607565

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Shock is a clinical disorder that challenges caregivers in the neonatal intensive care unit. The predominant cause of shock in neonates is sepsis. This article provides an overview of the current treatment of septic shock with particular emphasis on newer vasoactive drugs (milrinone, levosimendan and vasopressin) to support cardiovascular dysfunction.

引用

页码：17 / 19

页数：3

共 10 条

[1] Hemodynamic effects of IV milrinone lactate in pediatric patients with septic shock - A prospective, double-blinded, randomized, placebo-controlled, interventional study
Barton, P
Garcia, J
Kouatli, A
Kitchen, L
Zorka, A
Lindsay, C
Lawless, S
Giroir, B
[J]. CHEST, 1996, 109 (05) : 1302 - 1312
[2] Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine
Brierley, Joe
Carcillo, Joseph A.
Choong, Karen
Cornell, Tim
DeCaen, Allan
Deymann, Andreas
Doctor, Allan
Davis, Alan
Duff, John
Dugas, Marc-Andre
Duncan, Alan
Evans, Barry
Feldman, Jonathan
Felmet, Kathryn
Fisher, Gene
Frankel, Lorry
Jeffries, Howard
Greenwald, Bruce
Gutierrez, Juan
Hall, Mark
Han, Yong Y.
Hanson, James
Hazelzet, Jan
Hernan, Lynn
Kiff, Jane
Kissoon, Niranjan
Kon, Alexander
Irazusta, Jose
Lin, John
Lorts, Angie
Mariscalco, Michelle
Mehta, Renuka
Nadel, Simon
Nguyen, Trung
Nicholson, Carol
Peters, Mark
Okhuysen-Cawley, Regina
Poulton, Tom
Relves, Monica
Rodriguez, Agustin
Rozenfeld, Ranna
Schnitzler, Eduardo
Shanley, Tom
Skache, Sara
Skippen, Peter
Torres, Adalberto
von Dessauer, Bettina
Weingarten, Jacki
Yeh, Timothy
Zaritsky, Arno
[J]. CRITICAL CARE MEDICINE, 2009, 37 (02) : 666 - 688
[3] Hemodynamic support in fluid-refractory pediatric septic shock
Ceneviva, G
Paschall, JA
Maffei, F
Carcillo, JA
[J]. PEDIATRICS, 1998, 102 (02) : art. no. - e19
[4] Evidence-based use of levosimendan in different clinical settings
De Luca, Leonardo
Colucci, Wilson S.
Nieminen, Markku S.
Massie, Barry M.
Gheorghiade, Mihai
[J]. EUROPEAN HEART JOURNAL, 2006, 27 (16) : 1908 - 1920
[5] The scenarios of shock in newborn infants
Giliberti, Paolo
Giordano, Lucia
Chello, Giovanni
De Leonibus, Chiara
Giliberti, Paola
[J]. JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2010, 23 : 27 - 29
[6] Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2
[7] Use of levosimendan, a new inodilator, for postoperative myocardial stunning in a premature neonate
Lechner, Evelyn
Moosbauer, Werner
Pinter, Miklos
Mair, Rudolf
Tulzer, Gerald
[J]. PEDIATRIC CRITICAL CARE MEDICINE, 2007, 8 (01) : 61 - 63
[8] Role of terlipressin in the treatment of infants and neonates with catecholamine-resistant septic shock
Leone, Marc
Martin, Claude
[J]. BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY, 2008, 22 (02) : 323 - 333
[9] Noradrenaline for management of septic shock refractory to fluid loading and dopamine or dobutamine in full-term newborn infants
Tourneux, Pierre
Rakza, Thameur
Abazine, Abdel
Krim, Gerard
Storme, Laurent
[J]. ACTA PAEDIATRICA, 2008, 97 (02) : 177 - 180
[10] Pathophysiology and Treatment of Septic Shock in Neonates
Wynn, James L.
Wong, Hector R.
[J]. CLINICS IN PERINATOLOGY, 2010, 37 (02) : 439 - +

← 1 →